Christopher I Wright
Chief Medical Officer at Wave Life Sciences Ltd. (WVE) since April 2026
Christopher I Wright has filed 16 insider reports with the SEC since March 2021, as director at Alkermes plc. (ALKS), chief Medical Officer at Wave Life Sciences Ltd. (WVE) and officer at Cyclerion Therapeutics, Inc. (KRSA). In the last 12 months Christopher I Wright sold $90.2K of stock on the open market. In the latest filing, on June 13, 2026, Christopher I Wright sold 2,000 shares of Alkermes plc. (ALKS) for $90.2K at an average of $45.10.
- Filings
- 16
- Companies
- 3
- Bought on market
- None
- Sold on market
- $101K
Companies where Christopher I Wright is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| ALKS Alkermes plc. | Directorsince May 2022 | 25,680 | $90.2K | $45.90 | Jun 13, 2026 | ||
| WVE Wave Life Sciences Ltd. | Chief Medical Officersince April 2026 | 45,625 | $3.365 | Apr 18, 2026 | |||
| KRSA Cyclerion Therapeutics, Inc. | Officer | 42,728 | $10.5K | $31.05 | Mar 1, 2021 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jun 12, 2026-$90.2KALKSDirector Wright Christopher I sold $90,200 worth of Ordinary Shares (2,000 units at $45.10) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 25,680 unitsForm 4Open-market sale10b5-1 plan
- May 21, 2026ALKSDirector Wright Christopher I converted options into 6,142 units of Ordinary Shares and covered exercise/tax liability with 1,475 units of Ordinary Shares, increasing direct ownership by 20% to 27,680 unitsForm 4Grant or awardShares withheld for taxes or exercise priceExercise or conversion of a derivative
- Apr 9, 2026WVEChristopher I Wright became an insiderForm 3New insider
- Jun 8, 2025ALKSDirector Wright Christopher I converted options into 3,301 units of Ordinary Shares and covered exercise/tax liability with 793 units of Ordinary Shares, increasing direct ownership by 12% to 23,013 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- May 31, 2025ALKSDirector Wright Christopher I covered exercise/tax liability with 1,924 units of Ordinary Shares and converted options into 8,013 units of Ordinary Shares, increasing direct ownership by 42% to 20,505 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- May 21, 2025ALKSSEC Form 4 filed by Director Wright Christopher IForm 4Grant or award
- Jun 29, 2024ALKSDirector Wright Christopher I converted options into 6,104 units of Ordinary Shares and covered exercise/tax liability with 1,465 units of Ordinary Shares, increasing direct ownership by 47% to 14,416 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 8, 2024ALKSDirector Wright Christopher I covered exercise/tax liability with 793 units of Ordinary Shares and converted options into 3,301 units of Ordinary Shares, increasing direct ownership by 35% to 9,777 unitsForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- May 31, 2024ALKSSEC Form 4 filed by Wright Christopher IForm 4Grant or awardOther acquisition or disposition
- Jul 7, 2023ALKSSEC Form 4 filed by Wright Christopher IForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jun 29, 2023ALKSSEC Form 4 filed by Wright Christopher IForm 4Grant or award
- Jun 8, 2023ALKSSEC Form 4 filed by Wright Christopher IForm 4Shares withheld for taxes or exercise priceExercise or conversion of a derivative
- Jul 7, 2022ALKSSEC Form 4 filed by Wright Christopher IForm 4Grant or award
- Jun 8, 2022ALKSSEC Form 4 filed by Wright Christopher IForm 4Grant or award
- May 24, 2022ALKSChristopher I Wright became an insiderForm 3New insider
- Feb 25, 2021-$10.5KKRSASEC Form 4: I Christopher Wright sold $10,522 worth of Common Stock (2,637 units at $3.99), decreasing ownership by 6% to 42,728 unitsForm 4Open-market sale10b5-1 plan
Compare Christopher I Wright with
- Christopher I Wright vs David Joseph Gaffin1 shared
- Christopher I Wright vs Anne Clem Whitaker1 shared
- Christopher I Wright vs Michelle Patricia Pernice1 shared
- Christopher I Wright vs Nimish P Shah1 shared
- Christopher I Wright vs Andrew Gottesdiener1 shared
- Christopher I Wright vs Jonathan Violin1 shared
Other insiders at the same companies
- David Joseph GaffinALKS
- Anne Clem WhitakerALKS
- Michelle Patricia PerniceKRSA
- Nimish P ShahKRSA
- Fairmount Funds Management LLCKRSA
- Andrew GottesdienerKRSA
- Jonathan ViolinKRSA
- Matthew James LeoniKRSA
- Heidi HensonKRSA
- Mark J. VignolaKRSA
- Craig C. HopkinsonALKS
- Rhonda M. ChickoKRSA
- Regina Margaret GraulKRSA
- Christian Todd NicholsALKS
- Heidi L WagnerWVE
- Adrian RawcliffeWVE
Questions about Christopher I Wright
- What is Christopher I Wright's role at Wave Life Sciences Ltd.?
- Christopher I Wright reports to the SEC as chief Medical Officer at Wave Life Sciences Ltd. (WVE), according to the latest filing on April 18, 2026. Christopher I Wright has also filed as director at Alkermes plc. (ALKS) and officer at Cyclerion Therapeutics, Inc. (KRSA).
- How many shares does Christopher I Wright own?
- After the latest filing that states it, Christopher I Wright directly owned 25,680 shares of Alkermes plc. (ALKS), 45,625 shares of Wave Life Sciences Ltd. (WVE) and 42,728 shares of Cyclerion Therapeutics, Inc. (KRSA). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Christopher I Wright bought or sold stock recently?
- The most recent open-market sale was on June 12, 2026: sold 2,000 shares of Alkermes plc. (ALKS) for $90.2K at an average of $45.10.
- How do I get alerts when Christopher I Wright files?
- Follow Christopher I Wright on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Christopher I Wright (SEC CIK 0001838503). Totals count each trade once, skipping amendments whose original is on file, from Mar 1, 2021 on. View on SEC EDGAR